Skip to content
GenoLensGenoLens

PLCB1

Chr 20p12.3

phospholipase C beta 1

Aliases:
KIAA0581, PLC-I, PLC154
MANE:
ENST00000338037.11

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Early onset or syndromic epilepsy

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • developmental and epileptic encephalopathy, 12

    0.76
  • Abnormality of the skeletal system

    0.39
  • hypertensive disorder

    0.38
  • infantile spasms

    0.38
  • genetic developmental and epileptic encephalopathy

    0.37
  • malignant migrating partial seizures of infancy

    0.37
  • epilepsy of infancy with migrating focal seizures

    0.37
  • early-infantile DEE

    0.37
  • early infantile epileptic encephalopathy, autosomal recessive

    0.37
  • alcohol drinking

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1

Catalyzes the hydrolysis of 1-phosphatidylinositol 4,5-bisphosphate into diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) and mediates intracellular signaling downstream of G protein-coupled receptors (PubMed:9188725). Regulates the function of the endothelial barrier

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.